Connect with us

Headlines of The Day

Narayana Hrudayalaya’s consolidated Q3 FY22 net profit at Rs. 97.49cr

NHL reported strong numbers led by flagship hospitals amid recovery in high-end cardiac elective work as well as international patient mix.

  • Revenues were up 27.9% YoY to | 959.6 crore
  • EBITDA was at | 175 crore, up 66.8% YoY with margins at 18.2%
  • Adjusted PAT was at | 97.5 crore (up 138.9% YoY)

Key triggers for future price performance

  • Waning Covid and increase in footfalls for medical tourism expected to lead flagship hospitals on a steady growth path amid better returns
  • New hospitals (SRCC, Gurugram, Dharamshila) are likely to see reduction in losses and turn profitable in medium term with ramp up in occupancies
  • Improvement in numbers on the back of judicious case mix identification (more focus on oncology, transplants and non-invasive procedures)
  • Expansion at Cayman Islands in oncology while being margin dilutive in near term is likely to provide significant additional operating leverage

For full result update click.
MB Bureau

Copyright © 2023 Medical Buyer

error: Content is protected !!